-+ 0.00%
-+ 0.00%
-+ 0.00%

Rein Therapeutics Q1 EPS $(0.19) Beats $(0.49) Estimate

Benzinga·05/15/2026 13:27:24
Listen to the news
Rein Therapeutics (NASDAQ:RNTX) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.49) by 61.22 percent. This is a 24 percent increase over losses of $(0.25) per share from the same period last year.